News
The virtual care giant reported a $6.7 billion loss in the first quarter, driven by a non-cash goodwill impairment charge related to its 2020 Livongo deal.
Its fresh funds will support its product development and international expansion efforts.
The company aims to help the self-testing market grow by licensing its core technology for transforming smartphones into IVD devices.
The startup scooped up $14 million in Series A funding in January 2021.
Hinge's new offering comes nearly two months after competitor SWORD Health announced its own pelvic health program.
Its web-based platform also guides patients to access appropriate medical care.
It plans to expand its coverage in the domestic market.
Also: Impiricus raises a $3 million seed, and health tech VC Flare Capital Partners closes its $350 million third fund.
The offering includes treatment and screening for prediabetes and Type 2 diabetes.
Coming nearly two years after the company's $100 million Series C, Biofourmis tallied its total raise at $445 million.